Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of the Rheumatic Diseases

Topics

Medicine

Immunology

Internal Medicine

Gastroenterology

Pathology And Forensic Medicine

Show all topics

DOI

10.1136/annrheumdis-2013-204522

Other Formats

PDF